Medical robotics developer Robocath has raised €4.7m through a new round of fundraising to market its latest robotic platform called R-one for cardiovascular indications.

Led by M Capital and Normandie Participations, the round also involved Robocath’s past investors, Go Capital and NCI.

In 2013 and 2015, the firm raised €1.8m, to which €1.6m of public aid was added by other investors such as Bpifrance.

Designed to minimise exposure to X-rays, R-one is currently under manufacturing and in the process of securing CE mark.

Robocath chairman and founder Philippe Bencteux said: “The whole team and I would like to thank our historical shareholders, Go Capital and NCI, for their renewed support, and our bank partners BNP Paribas and La Caisse d’Epargne, and our new institutional shareholders for their strong buy-in to our plans.

"This new funding will help us to achieve a decisive milestone in our development strategy."

“This new funding will help us to achieve a decisive milestone in our development strategy. R-one is currently the only robotic assistance platform for interventional cardiology developed in Europe.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“We plan to build on this technological edge to enter the European market next year.”

The fully integrated robotics platform is claimed to enable remote management of instruments using a control panel placed adjacent to the operating table.

The new system is based on the R-grasp technology, which reproduces exact hand gestures such as rotation and simultaneous movement, and SecurAccess that offers stability and security during a medical procedure.

While R-one will be launched in Europe next year, it is expected to be introduced in the US in 2019.